UNITE: Efficacy and impact of fremanezumab in patients with migraine and major depressive disorder

被引：0

作者：

Ramirez Campos, V. ^{[1
]}

Lipton, R. B. ^{[2
]}

Krasenbaum, L. J. ^{[1
]}

Ning, X. ^{[1
]}

Barbanti, P. ^{[3
,4
]}

Roth-Ben Arie, Z. ^{[5
]}

Galic, M. ^{[6
]}

Denysenko, L. ^{[7
,8
]}

Marmura, M. ^{[7
]}

McAllister, P. ^{[9
]}

Mitsikostas, D. D. ^{[10
]}

机构：

[1] Teva Branded Pharmaceut Prod R&D Inc, W Chester, PA USA

[2] Albert Einstein Coll Med, Dept Neurol Psychiat & Behav Sci, New York, NY USA

[3] IRCCS San Raffaele Roma, Headache & Pain Unit, Rome, Italy

[4] San Raffaele Univ, Rome, Italy

[5] Teva Pharmaceut Ind Ltd, Petah Tiqwa, Israel

[6] TEVA PHARMA, Prod Farmaceut Lda, Porto Salvo, Portugal

[7] Thomas Jefferson Univ Hosp, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA 19107 USA

[8] Thomas Jefferson Univ Hosp, Dept Psychiat & Human Behav, Philadelphia, PA 19107 USA

[9] New England Inst Neurol & Headache, Stamford, CT USA

[10] Natl & Kapodistrian Univ Athens, Aeginit Hosp, Dept Neurol 1, Athens, Greece

来源：

JOURNAL OF HEADACHE AND PAIN | 2024年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P028

引用

下载

页数：1

共 50 条

[1] UNITE: Efficacy and Impact of Fremanezumab in Patients with Migraine and Major Depressive Disorder
Campos, Verena Ramirez
Lipton, Richard B.
Krasenbaum, Lynda J.
Ning, Xiaoping
Barbanti, Piero
Roth-Ben Arie, Zipora
Galic, Maja
Denysenko, Lex
Marmura, Michael
McAllister, Peter
Mitsikostas, Dimos
CEPHALALGIA, 2023, 43 (1supp) : 64 - 65
[2] Efficacy of fremanezumab in reducing depression in patients with migraine and major depressive disorder: results of the UNITE study
Lipton, R.
Barbanti, P.
Campos, Ramirez, V
Arie, Roth-Ben Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Denysenko, L.
HEADACHE, 2023, 63 : 133 - 134
[3] Efficacy of fremanezumab in reducing depression in patients with migraine and major depressive disorder: Results of the UNITE study
Lipton, Richard
Barbanti, Piero
Campos, Verena Ramirez
Roth-Ben Arie, Zipora
Krasenbaum, Lynda
Ning, Xiaoping
Galic, Maja
Denysenkoh, Lex
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[4] Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: results of the UNITE study
McAllister, P.
Ramirez, Campos, V
Roth-Ben, Arie Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Mitsikostas, D.
HEADACHE, 2023, 63 : 142 - 142
[5] Impact of fremanezumab treatment on disability outcomes in patients with migraine and major depressive disorder: Results of the UNITE study
Mcallister, Peter
Campos, Verena Ramirez
Roth-Ben Arie, Zipora
Krasenbaum, Lynda
Ning, Xiaoping
Galic, Maja
Mitsikostas, Dimos
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[6] Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: Results from the UNITE study
Lipton, Richard
Campos, Verena Ramirez
Arie, Zipora Roth-Ben
Krasenbaum, Lynda
Ning, Xiaoping
Galic, Maja
Marmura, Michael
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[7] Efficacy of fremanezumab treatment in reducing monthly migraine days in patients with migraine and major depressive disorder: results from the UNITE study
Lipton, R.
Campos, Ramirez, V
Roth-Ben, Arie Z.
Krasenbaum, L.
Ning, X.
Galic, M.
Marmura, M.
HEADACHE, 2023, 63 : 134 - 134
[8] A Phase 4 Study of Fremanezumab for Preventive Migraine Treatment in Patients With Major Depressive Disorder: Baseline Patient Characteristics in UNITE
Lipton, Richard B.
Campos, Verena Ramirez
Galic, Maja
Arie, Zipi Roth-Ben
Akcicek, Hasan
Lyras, Leonidas
Krasenbaum, Lynda J.
CEPHALALGIA, 2022, 42 (1_SUPPL) : 99 - 100
[9] The impact of migraine on patients with major depressive disorder
Hung, CI
Liu, CY
Juang, YY
Wang, SJ
HEADACHE, 2006, 46 (03): : 469 - 477
[10] Efficacy of fremanezumab in reducing Monthly Migraine Days (MMD) and depression severity in patients from european countries with Migraine and Major Depressive Disorder (MDD)
Tassorelli, C.
Mitsikostas, D. D.
Barbanti, P.
Akcicek, H.
Krasenbaum, L. J.
Campos, V. Ramirez
JOURNAL OF HEADACHE AND PAIN, 2024, 25

← 1 2 3 4 5 →